Innovative Anti-Aging Drug Targets Cells to Reverse Aging
Scientists from Queen Mary University of London have discovered that the drug Rapalink-1 extends the lifespan of yeast cells by targeting the TORC1 pathway, and this process involves increased production of enzymes that convert gut bacteria-produced agmatine into chemicals linked to aging, offering insights that could inform human aging and health.